The University of Illinois College of Medicine offers a four-year program leading to the MD degree at four different sites in Illinois: Chicago, Peoria, Rockford, and formerly Urbana–Champaign.

During the past decade, University of Illinois College of Medicine conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 4 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Illinois College of Medicine" #1 sponsor was "Actelion" with 2 trials, followed by "National Cancer Institute (NCI)" with 2 trials sponsored, "National Institute of Allergy and Infectious Diseases (NIAID)" with 2 trials sponsored, "Dan Blazer III, M.D." with 1 trials sponsored and "EpiDestiny, Inc." with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Illinois College of Medicine" #1 collaborator was "University of Illinois at Chicago" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Boston Medical Center" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 13 different institutions and companies that were collaborators in the rest 23 trials.

According to Clinical.Site data, the most researched conditions in "University of Illinois College of Medicine" are "HIV Infections" (2 trials), "Interstitial Lung Disease" (2 trials), "Scleroderma" (2 trials), "Sickle Cell Disease" (2 trials) and "AIDS-Related Lymphoma" (1 trials). Many other conditions were trialed in "University of Illinois College of Medicine" in a lesser frequency.

Most popular intervention types in "University of Illinois College of Medicine" are "Drug" (14 trials), "Other" (4 trials), "Biological" (3 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Cyclophosphamide" (2 trials), "Laboratory Biomarker Analysis" (2 trials), "Rituximab" (2 trials) and "Zidovudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of Illinois College of Medicine" are 15 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Illinois College of Medicine". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in University of Illinois College of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Illinois College of Medicine, 3 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".